KRAS-G12D inhibitor shows promise in advanced pancreatic cancer: phase 1b/2 trial results
A phase 1b/2 trial published in Nature Medicine demonstrates that HRS-4642, a targeted KRAS-G12D inhibitor combined with chemotherapy, achieves encouraging…
Editor's Top Picks
NHS Maternity Crisis: Why Cultural Change Lags Behind Safety Data
A landmark NHS inquiry into maternity services in Nottingham documents 500 cases of serious or avoidable harm affecting nearly 2,500…
Submit Your Paper to GMJ
All-trans vs Cis MK-7: The Isomer Problem Most Supplement Labels Hide
Two MK-7 molecules can share a label claim while only one works: the all-trans isomer is biologically active, the cis…
MK-7 vs MK-4: Why Half-Life Decides the Dose
Two menaquinones, one decisive number: MK-4 vanishes from blood in hours while MK-7 circulates for days. That difference is why…
Why Exactly 100% NRV: Vitamin A’s Narrow Safety Margin Explained
For most vitamins, the gap between daily reference and safety ceiling is vast. For vitamin A it is 3.75× —…
Why High-Dose Oral B12 Is the Evidence-Based Dose
500 µg of B12 is 20,000% of the reference value — a number that looks like marketing until you learn…
K2 vs K1: Why Menaquinones Reach Bone and Blood Vessels
One vitamin, two destinations: K1 serves the liver's clotting factory, while K2 circulates long enough to activate the proteins that…
Vitamin A and Pregnancy: The Teratogenicity Warning Explained
Retinoic acid is one of the master signals of embryonic development — which is exactly why excess preformed vitamin A…
Vitamin K and Warfarin: What Anticoagulated Patients Must Know
Warfarin works by blocking vitamin K. Any K1 or K2 intake pushes back — which is why starting a K2…
Researchers Push for Better Diagnostic Framework for Premenstrual Dysphoric Disorder
Researchers are working to standardize diagnostic criteria for Premenstrual Dysphoric Disorder (PMDD), a severe menstrual health condition affecting 3–8% of…